[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349588-105":59,"doc-detail-349588-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-pan-cancer-analysis-of-mex3a-in-human-tumors","Comprehensive pan-cancer analysis of MEX3A in human tumors","","MEX3A is an evolutionarily conserved RNA-binding protein containing two KH RNA-binding domains and a C-terminal RING domain, linking it to post-transcriptional regulation and protein modification. Although MEX3A has been reported in multiple individual cancers, its shared and cancer-specific roles across human malignancies are incompletely defined. This study integrates TCGA, GTEx, CPTAC, and additional datasets to assess expression, genetics, phosphorylation, clinical relevance, RNA modification associations, immune features, and functional enrichment, identifying prognostic correlations and tumor-immune network involvement.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-cancer-analysis-of-mex3a-in-human-tumors/349588/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-cancer-analysis-of-mex3a-in-human-tumors/349588.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is MEX3A and why is it relevant to cancer research?","Question",{"text":112,"@type":113},"MEX3A is an evolutionarily conserved RNA-binding protein with KH RNA-binding domains and a C-terminal RING domain, suggesting roles in post-transcriptional regulation and protein modification, which may impact cancer biology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the pan-cancer analysis of MEX3A performed in this study?",{"text":117,"@type":113},"The study integrates publicly available multi-omics datasets, including TCGA, GTEx, CPTAC, and other external resources, to evaluate expression, genetic alterations, phosphorylation, clinical relevance, RNA modification links, immune features, and functional enrichment across multiple tumor types.",{"name":119,"@type":110,"acceptedAnswer":120},"What prognostic and molecular associations were reported for MEX3A?",{"text":121,"@type":113},"Elevated MEX3A expression was associated with poor overall and disease-specific survival in cancers such as ACC, LIHC, MESO, and SARC. The study also reports frequent copy number amplification in several cancers and altered phosphorylation levels at specific residues in tumor tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349588,1790194129,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Zhang et al. Discover Oncology (2026) 17:1249 Discover Oncology  \n[https://doi.org/10.1007/s12672-026-05459-2](https://doi.org/10.1007/s12672-026-05459-2)  \nANALYSIS Open Access  \nComprehensive pan-cancer analysis of MEX3A in human tumors  \nXuezhong Zhang1†, Yongxin Pan1†, Ning Li2†, Meilin Gao1, Tingting Chu1 and Xuebin Zhang3*  \n†Xuezhong Zhang, Yongxin Pan and Ning Li shares first authorship.  \n*Correspondence: Xuebin Zhang [tank10@126.com](tank10@126.com)  \n1Department of Laboratory Medicine, Zibo Central Hospital, Zibo, Shandong, China 2Department of Pulmonary and Critical Care Medicine, Zibo Central Hospital, Zibo, Shandong, China 3Department of Anorectal Surgery, Dongying People’s Hospital (Dongying Hospital of Shandong Provincial Hospital Group), Dongying, China  \nAbstract  \nMEX3A is an evolutionarily conserved RNA-binding protein characterized by two KH RNA-binding domains and a C-terminal RING domain, suggesting potential roles in both post-transcriptional regulation and protein modification. Although MEX3A has been implicated in several individual cancer types, its shared and cancer-specific roles across human cancers remain incompletely understood. In this study, we performed a comprehensive pan-cancer analysis of MEX3A by integrating publicly available datasets, including TCGA, GTEx, CPTAC, and other external resources. We systematically evaluated MEX3A expression, genetic alterations, phosphorylation status, clinical relevance, RNA modification-related associations, immune-related features, and functional enrichment profiles across multiple tumor types. MEX3A was significantly upregulated in most cancers and showed associations with advanced pathological stage in several tumor types. Survival analyses indicated that elevated MEX3A expression was correlated with poor overall survival and disease-specific survival in cancers such as ACC, LIHC, MESO, and SARC, supporting its potential value as a prognostic biomarker. Genetic alteration analysis revealed frequent copy number amplification of MEX3A in several cancers, whereas these alterations were not consistently associated with survival outcomes. Proteomic analyses further identified altered phosphorylation levels at S338 and S462 in tumor tissues, suggesting that post-translational modification may contribute to the regulation of MEX3A activity ina cancer-type-specific manner. Correlation analyses showed that MEX3A expression was associated with RNA modification-related genes, immune modulators, immune checkpoint genes, tumor-infiltrating immune cells, tumor mutational burden, and microsatellite instability across different cancers. These findings suggest that MEX3Amay participate in RNA regulatory networks and tumor-immune microenvironment interactions. Functional enrichment analysis revealed that MEX3A-associated proteins are involved in pathways related to transcriptional dysregulation, mRNA stability, and translational regulation. However, as these findings are primarily based on bioinformatic and correlation-based analyses, they should not be interpreted as evidence that MEX3A is a validated therapeutic or immunotherapy target. Overall, this study provides a systematic pan-cancer characterization of MEX3A and supports its potential role as a prognostic biomarker and a hypothesis-generating candidate for future mechanistic and clinical validation.  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in t","cbCaibwyKaRuLGgD","https://ap.wps.com/l/cbCaibwyKaRuLGgD","pdf",10278022,24,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What is MEX3A and why is it relevant to cancer research?\",\"answer\":\"MEX3A is an evolutionarily conserved RNA-binding protein with KH RNA-binding domains and a C-terminal RING domain, suggesting roles in post-transcriptional regulation and protein modification, which may impact cancer biology.\"},{\"question\":\"How was the pan-cancer analysis of MEX3A performed in this study?\",\"answer\":\"The study integrates publicly available multi-omics datasets, including TCGA, GTEx, CPTAC, and other external resources, to evaluate expression, genetic alterations, phosphorylation, clinical relevance, RNA modification links, immune features, and functional enrichment across multiple tumor types.\"},{\"question\":\"What prognostic and molecular associations were reported for MEX3A?\",\"answer\":\"Elevated MEX3A expression was associated with poor overall and disease-specific survival in cancers such as ACC, LIHC, MESO, and SARC. The study also reports frequent copy number amplification in several cancers and altered phosphorylation levels at specific residues in tumor tissues.\"}]","Comprehensive pan-cancer analysis of MEX3A in human tumors | PDF",1790084433,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2859eef1fa1c78382164da147508d69.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e299045939f8c8afbe27c1e9293c3067.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/362dd5f045f8c9ebdd4565aa9e62d053.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ac221342c672e1762aadd0a8f793ecc.webp",980,1306]